MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202341080012 A) filed by Msn Laboratories Private Limited, R&D Center, Hyderabad, Telangana, on Nov. 24, 2023, for 'stable pharmaceutical composition of cabozantinib.'
Inventor(s) include Ravi Kumar Nithiyanandam; and Bala Krishnaiah Medum.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The present invention pertains to stable pharmaceutical compositions comprising cabozantinib or pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable excipient, which does not contain glidant(s). Preferably, the pharmaceutically acceptable salts of cabozantinib is cabozantinib S-malate. Furthermore, the present invention also covers liquid oral pharmaceutical composition and injectable dosage forms of cabozantinib or pharmaceutically acceptable salts thereof."
Disclaimer: Curated by HT Syndication.
